Skip to main content

Abstract

This chapter discusses the genetics, metabolic actions, substrates, inducers, and inhibitors of cytochrome P450 2E1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Koop DR, Morgan ET, et al. Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits. Chemistry. 1982;257:8472–80.

    CAS  Google Scholar 

  2. Koop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. 1992;6:724–30.

    PubMed  CAS  Google Scholar 

  3. Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology. 1993;79:795–807.

    Article  PubMed  CAS  Google Scholar 

  4. Sun F, Chen Y. Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis. Int J Tuberc Lung Dis. 2008;12(9):994–1002.

    PubMed  CAS  Google Scholar 

  5. Sandson NB. Drug-Drug Interaction Primer: A Compendium of Case Vignettes for the Practicing Clinician. Arlington: American Psychiatric Publishing, Inc; 2007. p. 359–60.

    Google Scholar 

  6. Peter R, Baker R. Hydroxylation of chlorzoxazone as a specific probe for human liver CYP2E1. Chem Res Toxicol. 1990;3:566–73.

    Article  PubMed  CAS  Google Scholar 

  7. Raucy JL, Lasker JM, et al. Induction of cytochrome P450IIE1 in the obese overfed rat. Molecul Pharmacol. 1991;39:275–80.

    CAS  Google Scholar 

  8. Lu Y, Cederbaum AI. CYP 2E1 and oxidative liver injury by alcohol. Free Radic Biol Med. 2008;44(5):723–38.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Chen TL, Uen TH, et al. Human cytochrome P450 mono-oxygenase system is suppressed by propofol. Br J Anaesth. 1995;74:558–62.

    Article  PubMed  CAS  Google Scholar 

  10. Lejus C, Fautrel A, et al. Inhibition of cytochrome P450 2E1 by propofol in human and porcine liver microsomes. Biochem Pharmacol. 2002;64:1151–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Benjamin S. Gmelch MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gmelch, B.S., Dull, R.O. (2015). CYP2E1: The Anesthesia Enzyme. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7495-1_6

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7494-4

  • Online ISBN: 978-1-4614-7495-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics